HLA-A and cancer: Furthermore, CTLs directed to tumor-associated antigens survivin2B and PBF could be induced from CD8+CD73+CD45RA+CD62L+CXCR3+ cells of HLA-A*24:02+ cancer patients (Fig. 5I).